Autoimmune Diseases Linked to Higher Risk of Myelodysplastic Syndromes

New research underscores a clear link between myelodysplastic syndromes (MDS) and autoimmune diseases. Studies indicate that having one condition may elevate the risk of developing the other. Up to 30% of individuals with MDS also live with an autoimmune disorder, indicating a significant overlap.

MDS appears connected to several autoimmune and inflammatory diseases, including hypothyroidism, systemic lupus erythematosus (SLE), and inflammatory bowel disease (IBD). Among these, hypothyroidism carries the highest risk for MDS when compared to IBD or SLE. Those with Hashimoto thyroiditis, a form of hypothyroidism, face around a 52% greater genetic likelihood of developing MDS.

Within IBD, Crohn's disease shows a stronger association with MDS than ulcerative colitis. SLE also stands out as a notable risk factor, with higher MDS rates than other rheumatological conditions. Researchers believe shared triggers, genetic predispositions, and overlapping disease processes may explain the frequent co-occurrence.

Despite these findings, specific 2023 data on new MDS cases combined with autoimmune diseases in Germany remains unavailable.

The two-way relationship between MDS and autoimmune conditions suggests that early monitoring could be crucial for at-risk groups. Individuals with autoimmune disorders, particularly hypothyroidism or SLE, may need closer observation for potential MDS development. Further research could help clarify the exact mechanisms behind this connection.